Skip to main content

Advertisement

Log in

Psychometric Properties of Generic Preference-Weighted Measures for Children and Adolescents: A Systematic Review

  • Systematic Review
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Introduction

Preference-weighted measures (PWMs)—also referred to as preference-based measures in the literature—of health status/health-related quality of life plays an essential role in estimating quality-adjusted life-years (QALY) for use in economic evaluations of healthcare products and interventions. However, as PWMs are first and foremost intended to accurately reflect respondent health status, they should ideally demonstrate good psychometric properties for the population in question. This study aimed to systematically review published evidence on the measurement properties of commonly used PWMs for children and adolescents.

Methods

Three electronic databases (PubMed, Medline, and PsycINFO) were searched for articles assessing the psychometric properties (content validity, construct validity—including convergent validity and known-group validity, test-retest reliability, and responsiveness) of the PWMs of interest (AQoL-6D, CHU9D, HUI2, HUI3, and EQ-5D-Y). The COsensus-based Standards for the selection of health Measurement INstruments methodology (COSMIN) guidelines were used to assess (a) the methodological quality of the studies included and (b) the psychometric performance of the instruments covered. Data were analysed overall as well as by population (country and disease group) and perspective (self-report or proxy-report). The study protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) database (CRD42021277296).

Results

In total, 53 articles were included in this systematic review. Health Utilities Index (HUI) was tested only in patient populations, CHU9D was most frequently tested in general population samples, while EQ-5D-Y was tested in both populations. Overall, there was high-quality evidence supporting sufficient construct validity for all instruments except AQoL-6D. Evidence supporting test-retest and responsiveness was scarce. There was high-quality evidence supporting sufficient responsiveness of HUI2 and HUI3, and inconsistent test-retest reliability of CHU9D and EQ-5D-Y. Evidence for content validity was minimal and therefore not extracted and synthesized for any PWMs.

Conclusion

This review provides updated evidence on the measurement properties of existing generic PWMs for children and adolescents. High-quality evidence for all relevant psychometric properties and across a range of populations was not available for any of the instruments included, indicating that further work is needed in this direction. This study has identified some of the most noticeable evidence gaps for each of the individual measures. Users can use this information to guide their decision on the choice of PWM to administer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Brazier JE, Dixon S, Ratcliffe J. The role of patient preferences in cost-effectiveness analysis. Pharmacoeconomics. 2009;27(9):705–12.

    Article  Google Scholar 

  2. Allen JD, et al. The value of addressing patient preferences. Value Health. 2017;20(2):283–5.

    Article  Google Scholar 

  3. Boivin A, et al. Patient and public involvement in clinical guidelines: international experiences and future perspectives. Qual Saf Health Care. 2010;19(5):e22–e22.

    Google Scholar 

  4. Prinsen CA, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–57.

    Article  CAS  Google Scholar 

  5. Feng Y, et al. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D. Qual Life Res. 2017;26(8):2067–78.

    Article  Google Scholar 

  6. Sullivan SM, Tsiplova K, Ungar WJ. A scoping review of pediatric economic evaluation 1980–2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599–607.

    Article  Google Scholar 

  7. Wolstenholme JL, et al. Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: a review and UK-based focus group assessment of patient and parent choices. Qual Life Res. 2018;27(7):1769–80.

    Article  Google Scholar 

  8. Kwon J, et al. A systematic review and meta-analysis of childhood health utilities. Med Decis Making. 2018;38(3):277–305.

    Article  Google Scholar 

  9. Kwon J, et al. Systematic review of conceptual, age, measurement and valuation considerations for generic multidimensional childhood patient-reported outcome measures. Pharmacoeconomics. 2022;2:1–53.

    Google Scholar 

  10. Apajasalo M, et al. Quality of life in early adolescence: a sixteendimensional health-related measure (16D). Qual Life Res. 1996;5(2):205–11.

    Article  CAS  Google Scholar 

  11. Apajasalo M, et al. Quality of life in pre-adolescence: a 17-dimensional health-related measure (17D). Qual Life Res. 1996;5(6):532–8.

    Article  CAS  Google Scholar 

  12. Beusterien KM, et al. Development of the multi-attribute adolescent health utility measure (AHUM). Health Qual Life Outcomes. 2012;10(1):1–9.

    Article  Google Scholar 

  13. Moodie M, et al. Predicting time trade-off health state valuations of adolescents in four Pacific countries using the assessment of quality-of-life (AQoL-6D) instrument. Value Health. 2010;13(8):1014–27.

    Article  Google Scholar 

  14. Kang E. Validity of child health-6 dimension (Ch-6d) for adolescents. Value Health. 2016;19(7):A854.

    Article  Google Scholar 

  15. Stevens K. Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Qual Life Res. 2009;18(8):1105–13.

    Article  Google Scholar 

  16. Torrance GW, et al. Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index Mark 2. Med Care. 1996;2:702–22.

    Article  Google Scholar 

  17. Furlong WJ, et al. The health utilities index (HUI®) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33(5):375–84.

    Article  CAS  Google Scholar 

  18. Wille N, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875–86.

    Article  Google Scholar 

  19. Kreimeier S, et al. EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories. Qual Life Res. 2019;28(7):1951–61.

    Article  Google Scholar 

  20. Kaplan RM, Sieber WJ, Ganiats TG. The quality of well-being scale: comparison of the interviewer-administered version with a self-administered questionnaire. Psychol Health. 1997;12(6):783–91.

    Article  Google Scholar 

  21. Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the index of well-being. Health Serv Res. 1976;11(4):478.

    CAS  Google Scholar 

  22. Bailey C, et al. Preference elicitation techniques used in valuing children’s health-related quality-of-life: a systematic review. Pharmacoeconomics. 2022;2:1–36.

    Google Scholar 

  23. Rowen D, et al. A review of the psychometric performance of selected child and adolescent preference-based measures used to produce utilities for child and adolescent health. Value Health. 2021;24(3):443–60.

    Article  Google Scholar 

  24. Noyes J, Edwards R. EQ-5D for the assessment of health-related quality of life and resource allocation in children: a systematic methodological review. Value Health. 2011;14(8):1117–29.

    Article  CAS  Google Scholar 

  25. Janssens A, et al. A systematic review of generic multidimensional patient-reported outcome measures for children, part I: descriptive characteristics. Value Health. 2015;18(2):315–33.

    Article  Google Scholar 

  26. Cheng LJ, Tan RL-Y, Luo N. Measurement properties of the EQ VAS around the globe: a systematic review and Meta-regression analysis. Value Health. 2021;24(8):1223–33.

    Article  Google Scholar 

  27. Verstraete J, et al. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care. Health Qual Life Outcomes. 2022;20(1):1–14.

    Article  Google Scholar 

  28. Verstraete J, Scott D. The performance of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents with cerebral palsy (CP). Dialogues in Health. 2022;2:100032.

    Article  Google Scholar 

  29. Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1–11.

    Article  Google Scholar 

  30. Longworth L, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;2:2.

    Google Scholar 

  31. Fayers PM, Machin D. Quality of life: the assessment, analysis and reporting of patient-reported outcomes. New York: John Wiley & Sons; 2015.

    Book  Google Scholar 

  32. Feeny D, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113–28.

    Article  Google Scholar 

  33. Richardson JR, et al. Construction of the descriptive system for the assessment of quality of life AQoL-6D utility instrument. Health Qual Life Outcomes. 2012;10(1):1–9.

    Article  Google Scholar 

  34. Barr RD, et al. Health status and health-related quality of life in survivors of cancer in childhood in Latin America: a MISPHO feasibility study. Int J Oncol. 2001;19(2):413–21.

    CAS  Google Scholar 

  35. Qian X, et al. Measurement properties of commonly used generic preference-based measures in East and South-East Asia: a systematic review. Pharmacoeconomics. 2020;38(2):159–70.

    Article  Google Scholar 

  36. Cohen J. Statistical power analysis for the behavioral sciences. New York: Routledge; 2013.

    Book  Google Scholar 

  37. Stevens KJ. Working with children to develop dimensions for a preference-based, generic, pediatric, health-related quality-of-life measure. Qual Health Res. 2010;20(3):340–51.

    Article  Google Scholar 

  38. Krig S, et al. Acceptability of the health-related quality of life instrument EQ-5D-Y-5L among patients in child and adolescent psychiatric inpatient care. Acta Paediatr. 2021;110(3):899–906.

    Article  Google Scholar 

  39. Poder TG, et al. Canadian French translation and linguistic validation of the child health utility 9D (CHU9D). Health Qual Life Outcomes. 2018;16(1):1–7.

    Article  Google Scholar 

  40. Oluboyede Y, Tubeuf S, McCabe C. Measuring health outcomes of adolescents: report from a pilot study. Eur J Health Econ. 2013;14(1):11–9.

    Article  Google Scholar 

  41. Szecket N, et al. Preliminary translation and cultural adaptation of health utilities index questionnaires for application in Argentina. Int J Cancer. 1999;83(S12):119–24.

    Article  Google Scholar 

  42. Stevens K. Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation. Appl Health Econ Health Policy. 2011;9(3):157–69.

    Article  Google Scholar 

  43. Chen G, et al. Assessing the health-related quality of life of Australian adolescents: an empirical comparison of the child health utility 9D and EQ-5D-Y instruments. Value Health. 2015;18(4):432–8.

    Article  Google Scholar 

  44. Zanganeh M, et al. An assessment of the construct validity of the child health utility 9D-CHN instrument in school-aged children: evidence from a Chinese trial. Health Qual Life Outcomes. 2021;19(1):205.

    Article  Google Scholar 

  45. Ratcliffe J, et al. An assessment of the construct validity of the CHU9D in the Australian adolescent general population. Qual Life Res. 2012;21(4):717–25.

    Article  Google Scholar 

  46. Stevens KJ, Freeman JV. An assessment of the psychometric performance of the Health Utilities Index 2 and 3 in children following discharge from a UK pediatric intensive care unit. Pediatr Crit Care Med. 2012;13(4):387–92.

    Article  Google Scholar 

  47. Bashir NS, et al. An assessment of the validity and reliability of the pediatric child health utility 9D in children with inflammatory bowel disease. Children. 2021;8:5.

    Article  Google Scholar 

  48. Foster Page LA, et al. Can the child health utility 9D measure be useful in oral health research? Int J Paediatr Dent. 2015;25(5):349–57.

    Article  Google Scholar 

  49. Feeny D, et al. Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons. Soc Sci Med. 2004;58(4):799–809.

    Article  Google Scholar 

  50. Kennedy CR, Leyland K. Comparison of screening instruments for disability and emotional/behavioral disorders with a generic measure of health-related quality of life in survivors of childhood brain tumors. Int J Cancer Suppl. 1999;12:106–11.

    Article  CAS  Google Scholar 

  51. Ryan JM, et al. Comparison of the CHU-9D and the EQ-5D-Y instruments in children and young people with cerebral palsy: a cross-sectional study. BMJ Open. 2020;10(9): e037089.

    Article  Google Scholar 

  52. Sung L, et al. Construct validation of the health utilities index and the child health questionnaire in children undergoing cancer chemotherapy. Br J Cancer. 2003;88(8):1185–90.

    Article  CAS  Google Scholar 

  53. Petersen KD, et al. The construct validity of the child health utility 9D-DK instrument. Health Qual Life Outcomes. 2019;17(1):187.

    Article  Google Scholar 

  54. Le Galès C, et al. Cross-cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3. Int J Cancer Suppl. 1999;12:112–8.

    Article  Google Scholar 

  55. Burström K, et al. EQ-5D-Y as a health-related quality of life measure in children and adolescents with functional disability in Sweden: testing feasibility and validity. Acta Paediatr. 2014;103(4):426–35.

    Article  Google Scholar 

  56. Klaassen RJ, et al. Evaluating the ability to detect change of health-related quality of life in children with Hodgkin Disease. Cancer. 2010;116(6):1608–14.

    Article  Google Scholar 

  57. Dickerson JF, et al. Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression. Qual Life Res. 2018;27(2):447–54.

    Article  Google Scholar 

  58. Lindvall K, et al. Feasibility, reliability and validity of the health-related quality of life instrument Child Health Utility 9D (CHU9D) among school-aged children and adolescents in Sweden. Health Qual Life Outcomes. 2021;19(1):193.

    Article  Google Scholar 

  59. Wong CKH, et al. A head-to-head comparison of five-level (EQ-5D-5L-Y) and three-level EQ-5D-Y questionnaires in paediatric patients. Eur J Health Econ. 2019;20(5):647–56.

    Article  Google Scholar 

  60. Smith-Olinde L, et al. Health state preference scores for children with permanent childhood hearing loss: a comparative analysis of the QWB and HUI3. Qual Life Res. 2008;17(6):943–53.

    Article  Google Scholar 

  61. Banks BA, Barrowman NJ, Klaassen R. Health-related quality of life: changes in children undergoing chemotherapy. J Pediatr Hematol Oncol. 2008;30(4):292–7.

    Article  Google Scholar 

  62. Verstraete J, et al. How does the EQ-5D-Y Proxy version 1 perform in 3, 4 and 5-year-old children? Health Qual Life Outcomes. 2020;18(1):149.

    Article  Google Scholar 

  63. Frew EJ, et al. Is utility-based quality of life associated with overweight in children? Evidence from the UK WAVES randomised controlled study. BMC Pediatr. 2015;15:211.

    Article  Google Scholar 

  64. Wolf RT, et al. The longitudinal validity of proxy-reported CHU9D. Qual Life Res. 2021;30(6):1747–56.

    Article  Google Scholar 

  65. Mayoral K, et al. Measurement properties of the online EuroQol-5D-Youth Instrument in children and adolescents with type 1 diabetes mellitus: questionnaire study. J Med Internet Res. 2019;21(11):e14947.

    Article  Google Scholar 

  66. Stevens K, Ratcliffe J. Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. Value Health. 2012;15(8):1092–9.

    Article  Google Scholar 

  67. Xu F, et al. Measuring and valuing health-related quality of life among children and adolescents in Mainland China—a pilot study. PLoS ONE. 2014;9:2.

    Google Scholar 

  68. Petersen KD, et al. Measuring health-related quality of life in adolescent populations: an empirical comparison of the CHU9D and the PedsQL(TM) 4.0 short form 15. Patient. 2018;11(1):29–37.

    Article  Google Scholar 

  69. Lynch FL, et al. Measuring health-related quality of life in teens with and without depression. Med Care. 2016;54(12):1089–97.

    Article  Google Scholar 

  70. Nixon Speechley K, et al. Mutual concurrent validity of the child health questionnaire and the health utilities index: an exploratory analysis using survivors of childhood cancer. Int J Cancer Suppl. 1999;12:95–105.

    Article  CAS  Google Scholar 

  71. Ungar WJ, et al. A parent-child dyad approach to the assessment of health status and health-related quality of life in children with asthma. Pharmacoeconomics. 2012;30(8):697–712.

    Article  Google Scholar 

  72. Roberts G, et al. Parent-reported health in extremely preterm and extremely low-birthweight children at age 8 years compared with comparison children born at term. Dev Med Child Neurol. 2011;53(10):927–32.

    Article  Google Scholar 

  73. Page LA, et al. The potential of the child health utility 9D index as an outcome measure for child dental health. BMC Oral Health. 2014;14:90.

    Article  Google Scholar 

  74. Tilford JM, et al. Preference-based health-related quality-of-life qutcomes in children with autism spectrum disorders: a comparison of generic instruments. Pharmacoeconomics. 2012;30(8):661–79.

    Article  Google Scholar 

  75. Yang P, et al. Psychometric evaluation of the Chinese version of the child health utility 9D (CHU9D-CHN): a school-based study in China. Qual Life Res. 2018;27(7):1921–31.

    Article  Google Scholar 

  76. Trudel J, et al. Psychometric properties of the health utilities index mark 2 system in paediatric oncology patients. Qual Life Res. 1998;7(5):421–32.

    Article  CAS  Google Scholar 

  77. Wong CKH, et al. Responsiveness of EQ-5D youth version 5-level (EQ-5D-5L-Y) and 3-level (EQ-5D-3L-Y) in patients with idiopathic scoliosis. Spine. 2019;44(21):1507–14.

    Article  Google Scholar 

  78. Boran P, et al. Translation and cultural adaptation of health utilities index with application to pediatric oncology patients during neutropenia and recovery in Turkey. Pediatr Blood Cancer. 2011;56(5):812–7.

    Article  Google Scholar 

  79. Scott D, Ferguson GD, Jelsma J. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness—a longitudinal, analytical study. Health Qual Life Outcomes. 2017;15(1):12.

    Article  Google Scholar 

  80. Willems DCM, et al. Using EQ-5D in children with asthma, rheumatic disorders, diabetes, and speech/language and/or hearing disorders. Int J Technol Assess Health Care. 2009;25(3):391–9.

    Article  Google Scholar 

  81. Scott D, et al. Validity and feasibility of the self-report EQ-5D-Y as a generic Health-Related Quality of Life outcome measure in children and adolescents with Juvenile Idiopathic Arthritis in Western Cape, South Africa. S Afr J Physiother. 2019;75(1):1335.

    Article  Google Scholar 

  82. Furber G, Segal L. The validity of the Child Health Utility instrument (CHU9D) as a routine outcome measure for use in child and adolescent mental health services. Health Qual Life Outcomes. 2015;13:22.

    Article  Google Scholar 

  83. Kulpeng W, et al. Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections. BMC Pediatr. 2013;13:122.

    Article  Google Scholar 

  84. Ratcliffe J, et al. Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population. Value Health. 2012;15(5):730–6.

    Article  Google Scholar 

  85. Hinz A, et al. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23(2):443–7.

    Article  Google Scholar 

  86. Feeny DH. Health utilities index. Quality of life and pharmacoeconomics in clinical trials, 1996.

  87. Horsman J, et al. The health utilities index (HUI®): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1(1):1–13.

    Article  Google Scholar 

  88. Messick S, Linn RL. Educational measurement. 3rd ed. London: Macmillan Pub Co.; 1989. p. 13–103.

    Google Scholar 

  89. Moss PA. Themes and variations in validity theory. Educ Meas Issues Pract. 1995;14(2):5–13.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nan Luo.

Ethics declarations

Author contribution

Concept and design: NL, MH. Acquisition of data: RL-YT, SZS, LAC. Analysis and interpretation of data: RL-YT, SZS, LAC, NL. Drafting of the manuscript: RL-YT, NL. Critical revision of the paper for important intellectual content: RL-YT, NL, MH. Administrative, technical, or logistic support: RL-YT, SZS, LAC, NL. Supervision: NL.

Funding

This study was partially funded by the EuroQol Research Foundation (Grant no. EQ Project 232-2020RA).

Data availability

Data generated for the current study are included in this published article (and its supplementary files). They are also available from the corresponding author on reasonable request.

Conflict of interest

Luo and Herdman are members of the EuroQol Research Foundation. All other authors declare no conflicts of interest.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 27 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, R.LY., Soh, S.Z.Y., Chen, L.A. et al. Psychometric Properties of Generic Preference-Weighted Measures for Children and Adolescents: A Systematic Review. PharmacoEconomics 41, 155–174 (2023). https://doi.org/10.1007/s40273-022-01205-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-022-01205-y

Navigation